Penserra Capital Management LLC Horizon Therapeutics Public LTD CO Transaction History

Penserra Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$98.98 - $115.74 $791 - $925	8 Added 80.0%	18 $2,000
Q1 2023 Apr 24, 2023	BUY	$107.32 - $113.5 $1,073 - $1,135	10 New	10 $1,000
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $1.33 Million - $1.94 Million	-16,707 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $1.44 Million - $1.83 Million	16,707 New	16,707 $1.76 Million
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $831,068 - $1.05 Million	-12,404 Closed	0 $0

Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $685,072 - $991,451	12,404 New	12,404 $963,000
Q1 2020 May 14, 2020	SELL	$24.87 - $38.56 $113,257 - $175,602	-4,554 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $115,808 - $166,995	4,554 New	4,554 $155,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.